Carta Healthcare

Patient cohorts are groups of individuals with shared characteristics (like age, disease, treatment, or birth year) used in research, healthcare management, and clinical trials to study outcomes, develop interventions, and manage populations , enabling better disease understanding, targeted care, and efficient trial recruitment by analyzing trends over time. They're built using data from EHRs, allowing for segmentation for value-based care, identifying risk factors, and ensuring diverse representation in studies, crucial for improving health outcomes and driving medical discovery.123456

Key Aspects of Patient Cohorts

• Definition: A group sharing a common attribute, condition (e.g., diabetes), exposure (e.g., a specific drug), or time period (e.g., birth year).
• Purpose: To monitor long-term trends, compare outcomes, discover biomarkers, design studies, and manage population health.
• Types:
  • Research Cohorts: For clinical trials (e.g., all patients receiving a new treatment).
  • Population Health Cohorts: Grouped for proactive care (e.g., high-risk diabetics).
  • Infection Control Cohorts: Grouping patients with the same infection to prevent spread.
• Creation: Involves defining criteria (age, diagnoses, vitals, social factors) from EHRs, often using AI for large-scale analysis.
• Importance: Essential for evidence-based medicine, identifying risk, improving treatment efficacy, and ensuring equitable research by accounting for social determinants of health (SDOH).12345678910

How They Are Used

• Clinical Trials: Identifying eligible participants for recruitment.
• Observational Studies: Tracking groups over time to understand disease progression and risk factors.
• Value-Based Care: Segmenting patients to target interventions for better outcomes and lower costs.
• Biomarker Discovery: Finding markers that predict disease risk or treatment response.123456

Clinical trial optimization refers to the strategies and methodologies employed to enhance the efficiency, effectiveness, and success of clinical research studies.This involves streamlining processes, reducing costs, and accelerating the delivery of new treatments to patients according to the Center for MedTech Excellence.Key aspects include optimizing trial design, improving site selection and management, enhancing patient recruitment and retention, and leveraging data and technology.123456

Key Areas of Clinical Trial Optimization:

• Trial Design and Planning: This involves carefully designing the study protocol, selecting appropriate endpoints, and optimizing the study population.This includes choosing the right study design (e.g., adaptive designs, randomized controlled trials) and statistical methods.1234567891011
• Site Selection and Management: Identifying and partnering with research sites that are well-equipped, experienced, and capable of meeting the trial's requirements is crucial.Optimizing site selection and providing ongoing support can prevent delays and ensure data quality.12
• Patient Recruitment and Retention: Finding and enrolling eligible participants is a major challenge in clinical trials.Strategies like targeted recruitment campaigns, patient-friendly trial designs, and robust communication plans can improve recruitment and retention rates according to Worldwide Clinical Trials.1234
• Data Management and Analysis: Efficiently collecting, managing, and analyzing data is essential for drawing meaningful conclusions from clinical trials.Utilizing data platforms, integrating data from various sources, and employing advanced analytics can streamline this process.12345
• Technology and Innovation: Adopting technologies like electronic data capture (EDC) systems,telemedicine, and wearable devices can enhance data collection, remote monitoring, and patient engagement.1234567
• Risk-Based Monitoring (RBM): This approach focuses on identifying and mitigating risks throughout the trial lifecycle, optimizing resource allocation and reducing unnecessary monitoring activities.123456
• Adaptive Trial Designs: These designs allow for modifications to the trial protocol based on accumulating data, potentially leading to more efficient and informative studies.12345
• Real-World Evidence (RWE): Leveraging RWE from electronic health records and other sources can provide valuable insights into treatment effectiveness and safety in real-world settings.12345

Benefits of Clinical Trial Optimization:

• Reduced costs: Streamlining processes and improving efficiency can significantly lower the overall cost of clinical trials.12
• Faster timelines: Optimized trials can be completed more quickly, bringing new treatments to patients sooner.12
• Improved data quality: Enhanced data collection and management practices can lead to more reliable and trustworthy results.1234567
• Increased patient engagement: Focusing on patient needs and preferences can lead to better recruitment and retention rates.12
• Enhanced decision-making: Data-driven insights from optimized trials can inform better clinical and regulatory decisions.1234

Challenges in Clinical Trial Optimization:

• Data fragmentation: Many organizations struggle to integrate data from different sources, leading to inefficiencies.12
• Complex regulatory landscape: Navigating the evolving regulatory requirements for clinical trials can be challenging.123
• Lack of skilled personnel: Finding and retaining qualified personnel with expertise in clinical trial design, data management, and technology can be difficult.12345
• Patient recruitment and retention: Recruiting and retaining diverse and representative patient populations remains a significant hurdle.12345
• Integration of new technologies: Successfully integrating new technologies and platforms into existing clinical trial workflows can be complex.1234

By addressing these challenges and implementing effective optimization strategies, the clinical trial ecosystem can become more efficient, effective, and patient-centered, ultimately accelerating the development and delivery of new therapies.12

Clinical data management in 2026 is heavily driven by AI automation to fix inefficient workflows , with 71% of managers expecting to use more AI for data cleaning to reduce manual, time-consuming tasks. Key trends include the rise of autonomous AI agents for risk-based monitoring, blockchain integration for data security, and the need to manage complex, decentralized trial data streams.1234

Top 2025-2026 Clinical Data Management Trends:

• AI Agents for Risk-Based Monitoring: By 2026, the industry is shifting from simple AI tools to autonomous, domain-trained agents that actively interrogate data, generate synthetic validation data, and guide teams through decisions.
• Automation to Reduce Manual Tasks: With ~68% of managers citing manual data re-entry as a major bottleneck, automation is the #1 priority, with 12+ hours per week spent on manual,,, reconciliation.
• Decentralized Trial (DCT) Complexity: In 2025-2026, 7%-8% of trials include decentralized components, necessitating the integration of wearable devices, in-home diagnostics, and real-time patient data (ePROs).
• Blockchain for Data Integrity: Blockchain technology is increasingly adopted to ensure data security, provide immutable audit trails, and protect against tampering in, clinical research.
• Evolving Role of Data Managers: Clinical Data Managers (CDMs) are shifting from data stewards to data intelligence experts, needing to be involved earlier in protocol review and instrument design, especially for complex trials.
• Investment in Data Infrastructure: Companies like Carta Healthcare are receiving significant funding ($18.25M Series B1) for AI-powered, data abstraction to modernize,, health system data management.1234567

Key Challenges & Outlook:
While AI adoption is growing, experts warn against treating AI as a "nail looking for a hammer," emphasizing that, it must be used for the right, specific, use cases. Data accuracy, validation, and regulatory compliance remain, critical, concerns during this, transition.12

Clinical data abstraction companies provide services for extracting, organizing, and analyzing data from medical records to support quality reporting, research, and accreditation . Examples include Direct Difference, Registry Partners, American Data Network, e4health , and Carta Healthcare . These companies help healthcare organizations improve financial performance, meet regulatory requirements, and streamline workflows by outsourcing the complex task of data abstraction.12345

Services provided by clinical data abstraction companies

• Data extraction and abstraction: Abstracting data from electronic health records (EHRs) and paper charts for various registries and reporting needs.
• Core measure and registry support: Specializing in data abstraction for core measures and specific registries, such as those from the Centers for Medicare & Medicaid Services (CMS).
• Quality improvement and accreditation: Helping organizations meet accreditation standards (e.g., MBSAQIP, STS ) and supporting data-driven process improvements.
• EHR implementation and migration: Streamlining the data migration process during an EHR transition to ensure accuracy and completeness of patient information.
• Staff augmentation: Providing experienced abstractors to supplement an organization's internal team or serve as a complete outsourcing partner.1234567

How they help healthcare organizations

• Improve financial performance: Accurate data abstraction can lead to improved quality scores, which may result in better reimbursement and financial outcomes.
• Ensure regulatory compliance: They help ensure that organizations meet the reporting requirements of regulatory bodies and accrediting organizations.
• Free up staff: Outsourcing allows internal staff, such as clinical teams, to focus on patient care rather than data abstraction tasks.
• Enhance data accuracy and consistency: By employing trained professionals and validated methodologies, these companies help maintain high data quality and consistency across an organization.123456